|
|
Article: Market Edge Upgrades ARIAD Pharmaceuticals to Long (Buy).
- Article from:
- PR Newswire
- Article date:
- September 14, 2000
CopyrightCOPYRIGHT 2000 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
ATLANTA, Sept. 14 /PRNewswire/ --
Computrade Systems, Inc., developers of Market Edge(TM) and Second Opinion(TM), today upgraded ARIAD Pharmaceuticals (Nasdaq: ARIA) to a LONG (BUY).
Market Edge(TM) upgraded ARIA to Long (Buy) due to its improving technical conditions. The Market Edge(TM) Second Opinion(TM) notes that ARIA is under accumulation, has a strong upward chart pattern and has been outperforming the S&P 500 on a relative strength basis over the last 50 days. Stocks with a Long (Buy) opinion have positive supply and demand characteristics indicating a high likelihood of continued strong price performance over the near to intermediate term.
...